Skip to content
Home » INVESTORS

INVESTORS

elminda is Leading the Neural Revolution

540,000 standardized datasets and growing

Total addressable market in the US alone

Patents with innovation treatment opportunities​

Driving Innovation with elminda Data Platform

BNA™ Technology provides a flywheel effect that drives further growth & market offerings as the dataset grows.

  • Grows database with each new patient
  • Builds clinical insight
  • Develops capability and product opportunities
  • Drives application adoption

The commercial launch of BNA™ will further drive data growth and insight, along with topline revenue, with each additional patient.

Leveraging Big Data, Signal Processing, & AI

ROBUST COMPETITIVE ADVANTAGE

elminda has the world’s largest Medical Grade Standardized database of EEG & ERP recordings to provide clinicians with technology to clearly and accurately interpret brain function.

ATTRACTIVE BUSINESS MODEL

Recurring revenue and established reimbursement. Platform built to develop future biomarkers and companion diagnostics allowing for the expansion of existing pharma collaborations and partnerships to bring new drugs to market.

INNOVATIVE TREATMENT OPPORTUNITIES

The first practical and feasible way for front-line clinicians to objectively measured and compare brain function (cognition). The elminda Data Platform is FDA cleared(510k) & CE marked software platform with over 7 years of clinical experience and $75M capital invested.

Breakthrough Innovation

elminda Data Platform, powered by BNA™ technology, is the world’s largest Medical Grade standardized database with near-limitless potential growth.

February 2015

August 2015

November 2018

Market Opportunities

BNA™ Potential Primary Growth Channels

Depression
1. Psychiatry

BNA™ could improve treatment of depression significantly by objectively measuring brain health, improving and saving lives.

Dementia
2. Neurology

BNA™ could identify early on-set of dementia and possibly delay onset through optimised patient care.

3. Pharma Industry

BNA™ can help objectively quantify drug impact and develop patient response models.

Proven Utility Basis for Growth

Extensive previous experience provides tangible future development business opportunities.

We Invite You To Learn More

The neural revolution is multi-layered, complex and exciting – but it requires in-depth discussion and analysis of our go-to-market strategy, technology and data leadership. We encourage institutional investors to book time with our leadership team for a proper investor presentation.